Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Cash Flow Reinvestment Rate
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Cash Flow Reinvestment Rate of 1.27x as of September 2025, reinvesting CN¥11.62 Million (capex CN¥11.62 Million ) from operating cash flow of CN¥9.12 Million. Check 300942 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Shenzhen Bioeasy Biotechnology Co. Ltd. across 9 annual periods. Explore cash flow to debt ratio of Shenzhen Bioeasy Biotechnology Co. Ltd. to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year capital reinvestment analysis for Shenzhen Bioeasy Biotechnology Co. Ltd.. For live market cap and broader valuation context, see market cap of Shenzhen Bioeasy Biotechnology Co. Ltd..
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥54.67 Million | CN¥66.87 Million | CN¥45.90 Million | ▼ -87.0% |
| 2024 | 6.28x | CN¥215.23 Million | CN¥34.26 Million | CN¥174.10 Million | ▲ +161.3% |
| 2022 | 2.40x | CN¥366.80 Million | CN¥152.55 Million | CN¥176.85 Million | ▲ +21.4% |
| 2021 | 1.98x | CN¥506.07 Million | CN¥255.42 Million | CN¥79.51 Million | ▼ -19.3% |
| 2020 | 2.46x | CN¥156.65 Million | CN¥63.79 Million | CN¥82.84 Million | ▲ +259.2% |
| 2019 | 0.68x | CN¥45.97 Million | CN¥67.24 Million | CN¥26.29 Million | ▲ +276.1% |
| 2018 | 0.18x | CN¥10.53 Million | CN¥57.93 Million | CN¥10.53 Million | ▼ -60.3% |
| 2017 | 0.46x | CN¥10.82 Million | CN¥23.60 Million | CN¥10.82 Million | ▲ +84.4% |
| 2016 | 0.25x | CN¥9.03 Million | CN¥36.31 Million | CN¥9.03 Million | — |